After Seelos Therapeutics’ amyotrophic lateral sclerosis (ALS) candidate failed a phase 2/3 study, the biotech has filed for ...

A Virginia community has brought Christmas early to a woman with amyotrophic lateral sclerosis (ALS), who has just weeks to ...

The world's largest ALS patient-derived stem cell and biodata repository is now available to researchers globally.

A grant from the ALS Association will fund an early-stage clinical trial to test Tiziana's foralumab nasal spray in 20 ALS ...

Canadian neurosurgeons in partnership with Elon Musk's Neuralink have regulatory approval to recruit six patients with ...

Grammy winner John Driskell Hopkins, known as "Hop" from the Zac Brown Band, is turning his personal battle with amyotrophic ...

A surprise finding by two independent research teams and a venture capital mega-round have birthed a biotech looking to treat ...

Aimed at patients who are ineligible to take part in other clinical trials due to their advanced stage ALS, the trial hopes ...

Dannce.ai emerged from stealth with a platform that aims to use artificial intelligence to help diagnose and monitor movement ...

Almost all cases of ALS and half of frontotemporal dementia (FTD) cases are linked to dysfunction in a protein TDP-43.

Trace Neuroscience Launches with $101 Million Series A Financing to Expand Genomic Medicine for Neurodegenerative Diseases, ...